NCT05461573: An ongoing trial by Insud Pharma
This trial is completed, but has been granted a delay in reporting its results.
It must report results 1 year, 7 months from now.
Full data
| Full entry on ClinicalTrials.gov | NCT05461573 |
|---|---|
| Title | A Phase 3, Multi-Center, Non-Comparative Study to Evaluate the Contraceptive Efficacy, Safety, and Tolerability of LPRI-CF113 Administered Orally for 13 Medication Cycles |
| Results Status | Ongoing |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Aug. 2, 2022 |
| Completion date | Aug. 5, 2024 |
| Required reporting date | Aug. 5, 2027, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | Dec. 12, 2025 |
| Days late | None |